Analysis of Injectable Bone Graft Substitute Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Worldwide revenue from the injectable bone graft substitute market is estimated to stand at US$ 2.74 billion in 2024 and is slated to increase at a CAGR of 11.9% to reach US$ 8.45 billion by 2034.
Biologics are used as an alternative to autologous bone transplants, a procedure known as "bone graft substitute." Allograft, demineralized bone matrix, polymers, hydroxyapatite, and other components make up the alternatives. In orthopedics, these replacements are utilized to treat spinal fusion, union or non-union operations, and bone abnormalities. In addition, during the past ten years, the use of these alternatives has expanded due to their advantages, including safety, biocompatibility, and osteoconductivity to shattered bones.
The rise in the global market for bone grafts and replacements is ascribed to the rising prevalence of bone illnesses, such as infections and malignancies as well as the rising number of orthopedic procedures performed globally. In addition, throughout the projected period, the market is anticipated to develop because of the growing demand for synthetic alternatives and the soaring number of product approvals from several authorities. For example, in September 2019, the U.S. FDA granted Biogennix LLC 510(k) approval for Morpheus-C, a type-1 bovine collagen replacement for bone grafting.
Due to their advantages, injectable bone graft alternatives are used more. For example, it lessens the risks associated with bone grafting operations at the donor location. These alternatives have been utilized in dental implants more. As to the June 2021 Dental Tribune International article, a significant number of patients requested an implant treatment, indicating a positive trend for the accelerating demand for bone grafting.
These replacements assisted in building up the height and thickness of the jawbone, allowing a dental implant to be successfully placed and restoring the jawline's typical proportions. These products' advantages boost the use of dental bone grafts, which in turn propels the growth of the injectable bone graft replacement market as a whole. To address the growing demand in dental implantology, leading industry players are also actively focusing on the development of sophisticated bone graft substitutes with improved biocompatibility and effectiveness.
| Report Attribute | Detail |
|---|---|
| Injectable Bone Graft Substitute Market Size (2024E) | US$ 2.74 Billion |
| Forecasted Market Value (2034F) | US$ 8.45 Billion |
| Global Market Growth Rate (2024 to 2034) | 11.9% CAGR |
| North America Market Value (2024E) | US$ 1.04 Billion |
| Mexico Market Value (2034F) | US$ 281.92 Million |
| Foot and Ankle Segment Growth Rate (2024 to 2034) | 9.1% CAGR |
| Canada Market Value (2034F) | US$ 465.14 Million |
| Key Companies Profiled | Geistlich Pharma AG; Zimmer Biomet; ACE Surgical; BioHorizons; Baxter International Inc.; Intergra LiftSciences; Xtant Medical Holdings Inc.; Orthofix Holdings Inc.; NuVasive Inc.; Stryker Corporation. |
Growing instances of bone defects among individuals have fueled demand for bone grafting techniques in the healthcare industry, as per the injectable bone graft substitute industry outlook. As the need to conduct trauma and orthopedic surgeries persists, manufacturers are developing a range of bone grafts or bone graft substitutes to stimulate insufficient or impaired bone regeneration. Each surgeon faces difficulties in selecting the most suitable bone graft or bone graft substitute for each trauma and orthopedic surgical procedure that requires bone grafting.
Therefore, bone graft or bone graft substitute has several properties, such as biocompatibility, osteoconductive, osteoinductive, and osteogenic properties, as well as the biomaterial should provide sufficient mechanical support to allow for an optimal biomechanical environment in which bone regeneration occurs.
Since the inception of the first injectable bone substitutes, several products have been introduced and commercialized for orthopedic trauma, but still, a lack of knowledge has been observed amongst potential users about its usage and application. This unawareness denotes the sluggish growth of the global market.
Leading manufacturers are focusing on developing a range of premixed or directly mixed products, and new compounds that contain fibers that enhance the bending and shear strength of injectable bone grafts. Furthermore, products that are based on combinations of calcium phosphate (CP) mixtures and calcium sulfate (CS) compounds are also being developed. Thus, injectable bone substitutes, particularly CS, have also been targeted as potentially good carriers for antibiotics and growth factors.
The prevalence of orthopedic trauma among individuals and increasing instances of on-road accidents have encouraged demand for injectable bone graft substitutes in the healthcare industry. In addition, the growing incidence of bone and joint disorders among individuals, advancements in bone graft materials, and innovative product development propel the market toward growth.
However, lack of awareness about the features and benefits of these products, the high cost of the surgery, and ethical issues related to bone grafting are adversely affecting growth dynamics, as stated in the injectable bone graft substitute industry analysis.
The global market is segmented in terms of type, applications, and end users and has been studied thoroughly in the injectable bone graft substitute industry outlook. Preference for minimally invasive treatment procedures has encouraged manufacturers to develop injectable bone graft substitutes globally.
For example, arthroscopically assisted treatment with percutaneous internal fixation with an injectable bone graft substitute is one of the reliable and minimally invasive methods to achieve union and scaphoid healing. Since minimally invasive treatment procedures reduce the duration of hospital stay and offer rapid wound healing benefits, this creates a high demand for injectable bone graft substitutes.
Geographically, the global market is segmented into diverse regions, such as North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to represent a leading revenue contributor in the global market, as mentioned in the newly published injectable bone graft substitute industry analysis owing to the increasing inclination of patients towards minimally invasive treatment procedures.
The high geographical presence of leading players in the region is also driving the injectable bone graft substitute market. In addition, Europe is expected to account for the second largest share of the global market throughout the forecast period. However, the APEJ market is expected to record a robust CAGR attributed to the inventiveness in product offerings by the key players as well as the expansion of their geographical reach.
To remain at the forefront of the competitive market, leading market players are focusing on expanding their geographical presence and investing in product development.
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of several market factors on market segments and geographies.
What is driving the demand outlook for the injectable bone graft substitute market?
Growing instances of bone defects among individuals have fueled demand for bone graft substitute techniques in the healthcare industry.
Where will the growth spearhead in the global market?
North America is approximated to witness significant growth over the forecast period.
Which are the top players in the market?
Some of the key companies are DePuy Synthes, Medtronic PLC, Nuvasive, Inc., Orthofix Holdings, Inc., and Wright Medical Group N.V.
Table 01: Global Market US$ Mn Forecast by Region
Table 02: Global Market US$ Mn Forecast by Type
Table 03: Global Market US$ Mn Forecast by Application
Table 04: Global Market US$ Mn Forecast by End Users
Table 05: North America Market US$ Mn Forecast by Country
Table 06: North America Market US$ Mn Forecast by Type
Table 07: North America Market US$ Mn Forecast by Application
Table 08: North America Market US$ Mn Forecast by End Users
Table 09: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Type
Table 11: Latin America Market US$ Mn Forecast by Application
Table 12: Latin America Market US$ Mn Forecast by End Users
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Type
Table 15: Western Europe Market US$ Mn Forecast by Application
Table 16: Western Europe Market US$ Mn Forecast by End Users
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Type
Table 19: Eastern Europe Market US$ Mn Forecast by Application
Table 20: Eastern Europe Market US$ Mn Forecast by End Users
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Type
Table 23: East Asia Market US$ Mn Forecast by Application
Table 24: East Asia Market US$ Mn Forecast by End Users
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Type
Table 27: South Asia & Pacific Market US$ Mn Forecast by Application
Table 28: South Asia & Pacific Market US$ Mn Forecast by End Users
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Type
Table 31: MEA Market US$ Mn Forecast by Application
Table 32: MEA Market US$ Mn Forecast by End Users
Figure 01: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type
Figure 02: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 03: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 04: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 05: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type
Figure 06: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 07: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 08: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 09: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Injectable Bone Graft Substitute Market